Drug
Ifetroban clinical trials
Includes 3 studies of Ifetroban sodium.
- studies test it
- 10
- open now
- 1
- in phase 3
- 0
- first study started
- 2011
Keep track of what changes. Save the ifetroban studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
10 studies that test it; most in 2017 (3)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2014 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 10
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 3
Cumberland Pharmaceuticals (7) · Vanderbilt-Ingram Cancer Center (1) · Jeffrey Rade (1) · Brigham and Women's Hospital (1)
Studies
Open first, then newest update. How each study uses ifetroban is read from its arms, and is right about nine times in ten.
Testing it · 10
- Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)RecruitingPhase 2Cumberland PharmaceuticalsNCT05571059Written as Ifetroban Sodium
- Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial HypertensionActive, not recruitingPhase 2Cumberland PharmaceuticalsNCT02682511Written as Oral Ifetroban
- Oral Ifetroban in Subjects With Duchenne Muscular DystrophyCompletedPhase 2Cumberland PharmaceuticalsNCT03340675Written as Ifetroban
- Thromboxane Receptor Antagonist to Improve Endothelial FunctionCompletedPhase 2Jeffrey RadeNCT03962855Written as Ifetroban Sodium
- Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)CompletedPhase 2Cumberland PharmaceuticalsNCT03028350Written as Ifetroban Oral Capsule
- Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic RecurrenceActive, not recruitingPhase 2Vanderbilt-Ingram Cancer CenterNCT03694249Written as Ifetroban Sodium
- Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With IfetrobanCompletedPhase 2Brigham and Women's HospitalNCT03326063Written as Ifetroban
- Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic PatientsCompletedPhase 2Cumberland PharmaceuticalsNCT02802228Written as Ifetroban
- Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory DiseaseCompletedPhase 2Cumberland PharmaceuticalsNCT02216357Written as Ifetroban, Oral Capsule
- Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome PatientsCompletedPhase 2Cumberland PharmaceuticalsNCT01436500Written as Ifetroban Injection
Codes
What other systems call ifetroban · ClinicalTrials.gg INT003691
- MeSH (NLM) C078904ifetrobanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) E833KT807KIFETROBANConfirmed FDA, NLM, Wikidata
- Wikidata Q5991162IfetrobanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81570IfetrobanOne source FDA
- DrugBank DB12321One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C078904 | ifetroban | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | E833KT807K | IFETROBAN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q5991162 | Ifetroban | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81570 | Ifetroban | One source FDA |
| DrugBank | DB12321 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.